AV's are working
- Condition
- ME/CFS
- At worst
- Not stated
- Ill for
- Not stated
- Published
- Mar 2010
Summary
Combined long-term Valtrex and Famvir, and by 18 months in reported reaching roughly "90%" of baseline function, though symptoms returned within about a week whenever he tried stopping, so he cycled on and off every few months rather than quitting. In a later update, rating himself on Dr. Lerner's 1-10 fatigue scale, he described a longer arc: 3/10 rising to 9/10 after a year on Famvir alone, a relapse to 6/10 after switching to Valtrex, and eventual stabilization around 8/10 once Valcyte was added, enough to work full-time. He frames it as needing continuous antiviral maintenance rather than being cured.
What they credit
Credits Antivirals, Famvir / famciclovir (Pridgen), Valcyte / valganciclovir, Valtrex / valacyclovir.
Similar stories
-
Recovery Story Survey Suggests Some Commonalities
Alternates between Valcyte and either Famvir or Valtrex, cycling between antivirals, for ME/CFS complicated by recurrent bacterial and viral infections from immune dysfunction. On a rough 1-10 disability scale, says he has gone from a 3 to an 8, now varying…
-
Please Tell Me Your Valtrex + Valcyte Story
Starting from three naps a day and 8-10 hours in bed a night, "barely" able to keep his head up (a week-long Valtrex trial had caused adverse effects, so he avoided it), began Famvir plus Immunovir and started improving after about two months. He then added…
-
Björn recovered from severe ME with antivirals (valganciclovir, ritonavir and isentress)
Ran a long multi-drug protocol: valganciclovir at 450mg twice daily for a year then a lower maintenance dose for another 8 months, repeated after HHV-6 reactivated again; famciclovir 500mg three times daily for 6 months; gammaglobulin infusions every three…
-
ME/CFS, Valcyte, and me: Third time lucky
Tracy has tried valganciclovir (Valcyte) three times for ME/CFS: a six-month course in 2014 (three weeks of induction at two 450mg pills twice daily, then two pills once daily) cut short by an allergic reaction after switching to a generic mid-course; a…